Skip to main content
. 2020 Oct 21;146:111818. doi: 10.1016/j.fct.2020.111818

Table 3.

Probability of ADMET and toxicity profile of products predicted by MetaTox from ZEA α-ZEL and β-ZEL.


Metabolomic profile of ZEA
Metabolomic profile of α-ZEL and β-ZEL
Reaction
O-Glucuronidation
S-Sulfation
Hydrolysis
O-Glucuronidation
S-Sulfation
Hydrolysis
Metabolites
1z
2z
3z
4z
5z
1 ab
2 ab
3 ab
4 ab
5 ab
6 ab
7 ab
Probability (Prob) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%) Prob (%)
Absorption & Distribution
BBB 37.65 37.65 97.05 97.05 79.17 31.47 50.00 37.65 97.00 97.04 97.00 79.17
HIA 72.33 70.65 95.94 96.20 96.75 97.50 68.84 71.40 95.72 96.97 95.90 97.43
P-gp substrate 89.04 78.58 82.69 75.15 75.38 84.12 78.48 80.17 81.59 80.54 73.72 73.06
Caco-2 permeability 81.87 87.20 76.48 80.89 62.41 59.94 86.25 86.09 66.51 55.72 70.99 61.16
LogPapp (cm/s) −7.85 −8.24 −6.58 −6.97 −6.51 −7.96 −7.57 −7.42 −6.29 −6.14 −6.69 −6.16
Metabolism
CYP450 2C9 substrate 100 100 79.13 59.58 59.92 60.44 79.88 80.22 58.95 61.28 61.74 61.90
CYP450 2D6 substrate 87.97 88.12 86.54 86.41 86.75 83.54 87.85 87.74 85.62 86.69 85.35 86.83
CYP450 3A4 substrate 63.85 64.20 60.69 61.92 50.71 57.08 64.36 63.41 62.04 60.19 63.23 51.50
CYP450 1A2 inhibitor 57.71 74.19 73.02 76.60 53.79 57.71 69.70 72.83 69.70 64.06
CYP450 2C9 inhibitor 92.01 82.74 84.24 89.37 92.95 92.01 82.61 81.81 82.61 79.70
CYP450 2D6 inhibitor 92.29 87.55 90.45 90.07 91.41 92.29 87.62 86.89 87.62 90.48
CYP450 2C19 inhibitor 74.09 77.83 82.96 72.46 79.05 74.09 75.21 76.29 75.21 74.04
CYP450 3A4 inhibitor 73.18 84.7 64.02 76.82 73.89 73.18 75.62 78.53 75.62 61.88
Toxicity
AMES toxicity 68.00 66.00 73.00 66.00 79.00 85.00 67.00 70.00 68.79 76.79 60.79 74.00
Carcinogens 65.75 65.74 88.57 88.57 77.10 66.04 61.54 65.74 62.12 64.01 62.12 75.52
Rat acute toxicity (LD50, mol/kg) 2.65 2.22 2.50 2.03 2.36 1.94 2.36 2.45 2.77 2.37 2.3 2.27

BBB: blood-brain barrier; HIA: human gastrointestinal absorption; P-gp: P-glycoprotein.